How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

Multiple sclerosis (MS) is a neurological disorder characterized by inflammatory demyelination and neurodegeneration in the central nervous system. Until recently, disease-modifying treatment was based on agents requiring parenteral delivery, thus limiting long-term compliance. Basic treatments such...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazekas, Franz, Bajenaru, Ovidiu, Berger, Thomas, Fabjan, Tanja Hojs, Ledinek, Alenka Horvat, Jakab, Gábor, Komoly, Samuel, Kobys, Tetiana, Kraus, Jörg, Kurča, Egon, Kyriakides, Theodoros, Lisý, L'ubomír, Milanov, Ivan, Nehrych, Tetyana, Moskovko, Sergii, Panayiotou, Panayiotis, Jazbec, Saša Šega, Sokolova, Larysa, Taláb, Radomír, Traykov, Latchezar, Turčáni, Peter, Vass, Karl, Vella, Norbert, Voloshyná, Nataliya, Havrdová, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640198/
https://www.ncbi.nlm.nih.gov/pubmed/23641231
http://dx.doi.org/10.3389/fneur.2013.00010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640198/
https://www.ncbi.nlm.nih.gov/pubmed/23641231
http://dx.doi.org/10.3389/fneur.2013.00010

Ejemplares similares